News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Vertex Pharmaceuticals and NHS England Reach Landmark Reimbursement Agreement for ALYFTREK in Cystic Fibrosis, Pioneering Access to Once-Daily Combination Therapy Across the UK
Friday, October 31, 2025Vertex Pharmaceuticals has finalized a UKwide reimbursement deal with NHS England for ALYFTREK enabling broader access to its new cystic fibrosis therapy
NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series Developed by Aexon Labs
Friday, October 31, 2025NLS Pharmaceutics Ltd a Swiss clinicalstage biopharmaceutical company specialising in central nervous system CNS and neurodegenerative disorders together with Aexon Labs a biotechnology company focused
European Union Unveils Ambitious Life Science Growth Strategy to Cement Global Leadership by 2030
Thursday, October 30, 2025The European Union has launched a sweeping strategic initiative aimed at making Europe the worlds leading region for life sciences by with major investments regulatory reforms and sectorwide incentives
FDA grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the treatment of gastric cancer
Thursday, October 30, 2025Dewpoint Therapeutics has announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to DPTX its firstinclass condensate modulator developed for the treatment of gastric cancer
Amneal receives U.S. FDA tentative approval for beclomethasone dipropionate HFA inhalation aerosol
Thursday, October 30, 2025Amneal Pharmaceuticals Inc has announced that the US Food and Drug Administration FDA has granted tentative approval for the companys Abbreviated New Drug Application ANDA for beclomethasone dipropionate
European Commission Opens Biotech and Biomanufacturing Hub to Accelerate EU Life Sciences Innovation
Wednesday, October 29, 2025The European Commission announced the opening of a Biotech and Biomanufacturing Hub to drive pharmaceutical innovation and support SMEs across the European Union
Enigma Biomedical USA Announces FDA Acceptance of New Drug Application for Florquinitau F-18 (MK-6240), a Tau PET Radiodiagnostic for Alzheimer’s Disease
Wednesday, October 29, 2025Enigma Biomedical USA EB USA has announced that the US Food and Drug Administration FDA has accepted the New Drug Application NDA for florquinitau F MK a Tau Positron Emission Tomography
Harbour BioMed Introduces First Fully Human Generative AI HCAb Model to Advance Biologics Discovery
Wednesday, October 29, 2025Harbour BioMed a global biopharmaceutical company specialising in antibody therapeutics for immunology and oncology has launched its first fully human Generative AI HCAb Heavy ChainOnly Antibody Model
Revolution Medicines’ Daraxonrasib Receives U.S. FDA Orphan Drug Designation for Pancreatic Cancer
Tuesday, October 28, 2025Revolution Medicines Inc a latestage clinical oncology company focused on developing targeted therapies for RASdriven cancers announced that the US Food and Drug Administration FDA has granted Orphan
China’s NMPA grants Breakthrough Therapy Designation for anti-CTLA-4 antibody candidate Gotistobart (BNT316/ONC-392)
Tuesday, October 28, 2025OncoC announced that Chinas National Medical Products Administration NMPA has granted Breakthrough Therapy Designation BTD for gotistobart BNTONC to treat patients with squamous nonsmall
